Ibuprofen
General
- Type: NSAID
- Dosage Forms: Tablets: 100, 200, 400, 600, 800 mg. Suspension: 20mg/ml, 40 mg/ml
- Common Trade Names: Advil; Motrin
Adult Dosing
- 800mg PO Q8hours
- 400mg has been shown to be as effective at pain reduction as 600mg and 800mg[1]
Pediatric Dosing
- 10mg/kg PO Q6hours
- Max: 40mg/kg/day
Special Populations
- Pregnancy Rating: C (1st-2nd trimester), D (3rd trimester)
- Lactation risk categories: L4; enters breast milk, decreases milk supply
- Renal Dosing
- Adult: no adjustment
- Pediatric: no adjustment
- Hepatic Dosing
- Adult: not defined
- Pediatric: not defined
Contraindications
- Allergy to class/drug
- Cardiovascular
- May cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal
- Contraindicated for treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery
- Gastrointestinal risk
- Increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal
- Elderly patients are at greater risk for serious GI events.
- Increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal
Adverse Reactions
Serious
- Anaphylaxis
- GI bleeding
- Peptic ulcer disease, gastric perforation, bowel perforation
- Thromboycytopenia
- Agranulocytosis
- Steven-Johnson Syndrome
- Nephrotoxicity
Common
- Dyspepsia
- Nausea
- Abdominal pain
- Constipation
- Headache
- Dizziness
- Rash
- Fluid retention
- Ecchymosis
Pharmacology
- Half-life: 1.8 - 2 hr
- Metabolism: liver
- Excretion: Urine
- Mechanism of Action: exact mechanism unknown; inhibits cyclooxygenase, reducing prostaglandin and thromboxane synthesis
See Also
References
- ↑ Motov S, Masoudi A, Drapkin J, et al. Comparison of Oral Ibuprofen at Three Single-Dose Regimens for Treating Acute Pain in the Emergency Department: A Randomized Controlled Trial. Ann Emerg Med. 2019;74(4):530-537. doi:10.1016/j.annemergmed.2019.05.037